Skip to main content

Saratoga Research & Investment Management

Location
SARATOGA, CA
Portfolio Value
Mid $1,676,807,848
Diversification
Diversified
Filing Date
Global Rank
#1,096 / 8,232 ▲ 56
Top Industry
Drug Manufacturers - General 15.1%
3Y Alpha vs SPY
-8.6%
Period ended 2 months ago
Filed May 8, 2026 · 36d
25 quarters · since Mar 2020

Clone Performance

Jun 2023–Jun 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
+41.6%
SPY
+76.5%
Annualised alpha
-8.6%
Max drawdown
−16.5%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

41 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025
Top Position
10.5%
−2.2 pts
Top 5
40.4%
−1.2 pts
Top 10
66.8%
+0.4 pts
HHI
561
Jun 2023 → Mar 2026 · range 458 – 573
Diversified−12

Portfolio Trend

25 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2026
Sector % Portfolio Value
Healthcare 21.2% $355,935,571
Technology 20.2% $337,950,258
Communication Services 17.0% $284,350,365
Consumer Defensive 13.8% $231,293,533
Industrials 11.7% $196,394,866
Financial Services 10.6% $178,003,386
Consumer Cyclical 5.5% $92,676,442
Energy 0.0% $203,427

Last Quarter's Activity

Export CSV
Mar 31, 2026 vs Dec 31, 2025

Added To

Positions the filer increased
19 positions
Ticker Δ Shares Shares Value Open

Trimmed

Positions the filer reduced
14 positions
Ticker Δ Shares Shares Value Open

New Positions

Positions the filer opened this quarter
1 positions
Ticker Shares Value Open

Sold Out

Positions the filer fully exited
2 positions
Ticker Shares Value Open

Portfolio Positions

Export CSV View 13F filing
41 positions · $1,676,807,848 total · as of Mar 31, 2026
Ticker Company Shares Value (USD) % of Portfolio History